Related Experiment Videos
Inhalation toxicity studies of aqueous dispersion resin
1Norris Consulting Services, 6 West Grove, Harrogate, North Yorkshire HG1 2AD, United Kingdom.
Inhalation Toxicology
|March 15, 2000
Summary
Aqueous dispersion resin (ADR) inhalation studies found no toxic effects at acute exposure levels. However, repeated exposure in 9-day and 90-day studies showed lung effects, establishing a no-observable-effect level (NOEL) of 30 mg/m³.
Area of Science:
- Toxicology
- Environmental Health
- Polymer Science
Background:
- Aqueous dispersion resin (ADR) is a key component in hair-spray formulations, requiring safety assessments.
- Understanding the toxicological profile of ADR is crucial for consumer product safety.
Purpose of the Study:
- To evaluate the toxicological effects of Aqueous Dispersion Resin (ADR) through a series of inhalation studies.
- To determine the acute, sub-chronic (9-day), and chronic (90-day) toxicity of ADR aerosol exposure in animal models.
Main Methods:
- Conducted whole-body aerosol inhalation studies with varying durations (acute, 9-day, 90-day) and exposure concentrations.
- Utilized male and female rats, assessing clinical signs, body weight, lung weights, and histopathological changes.
- Determined LC50 for acute exposure and NOEL for the 90-day study.
Main Results:
- Acute exposure showed no mortality or lesions, with LC50 > 1.07 mg/L.
- 9-day exposure revealed alopecia and increased lung weights at higher concentrations (500-1000 mg/m³), with histopathological findings.
- 90-day exposure demonstrated increased lung weights and histopathological effects (alveolar histiocytosis, pneumonitis) at 100 and 300 mg/m³, but not at 30 mg/m³.
Conclusions:
- ADR is not acutely toxic via inhalation at tested concentrations.
- Repeated inhalation exposure to ADR can cause lung-related toxicity.
- A no-observable-effect level (NOEL) for 90-day inhalation exposure was established at 30 mg/m³.